Both ER subtypes are predominantly expressed through healthy CNS; however, in human astrocytomas, both ER-α [45,47,48,49] and ER-β [44] expression decreases as the grade of tumor malignancy increases. This evidence concerns the gene ESR1 and astrocytoma (excluding glioblastoma).